Stockscreener 앱 받기
1.11
2.63%
-0.03
시간 외 거래:
1.12
0.01
+0.90%
전일 마감가:
$1.14
열려 있는:
$1.14
하루 거래량:
782.57K
Relative Volume:
1.04
시가총액:
$142.83M
수익:
$514.70M
순이익/손실:
$2.72M
주가수익비율:
-6.9855
EPS:
-0.1589
순현금흐름:
$17.08M
1주 성능:
-13.28%
1개월 성능:
-23.97%
6개월 성능:
-57.31%
1년 성능:
-72.73%
1일 변동 폭
$1.10
$1.145
1주일 범위
$1.10
$1.28
52주 변동 폭
$1.10
$7.0771
Organogenesis Holdings Inc Stock (ORGO) Company Profile
명칭
Organogenesis Holdings Inc
전화
781-575-0775
주소
85 DAN ROAD, CANTON, MA
Compare ORGO vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
1.11 | 142.83M | 514.70M | 2.72M | 17.08M | -0.1589 |
TAK
Takeda Pharmaceutical Co Adr
|
19.45 | 62.13B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.11 | 47.95B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.94 | 43.71B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
78.42 | 32.40B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
541.51 | 23.23B | 3.17B | 1.29B | 1.01B | 27.09 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-05-28 | 개시 | Truist | Hold |
| 2026-05-08 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-06-28 | 개시 | Lake Street | Buy |
| 2024-02-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-24 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-08-26 | 재개 | Credit Suisse | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
| 2019-04-17 | 개시 | Oppenheimer | Outperform |
| 2019-04-11 | 개시 | SunTrust | Buy |
모두보기
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
For vesting taxes, Nikhil Chandhok has 3,815 Circle Internet Group (CRCL) shares withheld. - Stock Titan
Organogenesis stock trades without a fresh catalyst, recent results define the picture - ad-hoc-news.de
Organogenesis (ORGO) Quarter in Focus: Reported EPS Misses Expectations for the Current Session; Closing Reaction - vinanet.vn
ORGO | Organogenesis Holdings Inc. Class FinancialsRevenue Breakdown - Quiver Quantitative
Spotlighting Anixa Biosciences And 2 Other Noteworthy Penny Stocks - Sahm
Spotlighting Anixa Biosciences And 2 Other Noteworthy Penny Stocks - simplywall.st
Organogenesis (ORGO) Chart: Moves 3.35% Up to $1.85 on the Day; Current Setup: the Near-Term Reference Band Stretches From $1.76 to $1.94 in Latest TradingRSI Overbought Alerts - vinanet.vn
Organogenesis (ORGO) Chart: Moves 3.35% Up to $1.85 on the Day; Current Setup: the Near-Term Reference Band Stretches From $1.76 to $1.94 in Latest TradingPassive Flow - siam.in
Vanguard Morningstar Total Stock Market ETF Holdings - Quiver Quantitative
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript - AOL.com
Oragenics: Q2 Earnings Snapshot - AOL.com
Organogenesis, lured to RI with tax credits, is bleeding money - The Business Journals
OrganiGram: Fiscal Q3 Earnings Snapshot - AOL.com
Organogenesis Holdings, Inc. Class A Revenue Breakdown – MUN:2PQ - TradingView
Organogenesis Holdings (ORGO) Holds Flat at $1.86 as Shares Consolidate Between Support and ResistanceBuffered ETF - vinanet.vn
Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution - Yahoo Finance
Organogenesis Holdings Inc (ORGO) Stock News Today - TradingKey
Organogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed? - Yahoo Finance
Organogenesis (NASDAQ:ORGO) Cut to Strong Sell at Wall Street Zen - MarketBeat
Organogenesis Holdings Inc (ORGO) Stock News Today - TradingKey
Organogenesis Holdings Inc (ORGO) Stock News Today - TradingKey
Organogenesis Holdings Inc (ORGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Organogenesis Shares Plunge After Revenue Slump, Wider Loss and Lower Outlook - Moomoo
Truist Adjusts Price Target on Organogenesis to $2 From $3, Maintains Hold Rating - marketscreener.com
Truist Financial Has Lowered Expectations for Organogenesis (NASDAQ:ORGO) Stock Price - MarketBeat
Organogenesis Holdings Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Organogenesis Q2 2026 miss sends shares lower By Investing.com - Investing.com Australia
Form 8K Organogenesis Holdings Inc For: 6 August By Investing.com - Investing.com Nigeria
Earnings call transcript: Organogenesis Q2 2026 miss sends shares lower By Investing.com - Investing.com South Africa
Form 8K Organogenesis Holdings Inc For: 6 August By Investing.com - Investing.com South Africa
Earnings call transcript: Organogenesis Q2 2026 miss sends shares lower By Investing.com - Investing.com Nigeria
Organogenesis Holdings enters at-the-market sales agreement for up to $75 million - Investing.com Nigeria
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Potential 24% Upside For Investors - DirectorsTalk Interviews
Organogenesis Q2 Earnings Call Highlights - Yahoo Finance
Organogenesis earnings missed by $0.42, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Organogenesis Q2 2026 miss sends shares lower - Investing.com
Organogenesis Holdings enters at-the-market sales agreement for up to $75 million - Investing.com
Transcript : Organogenesis Holdings Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
Organogenesis: Q2 Earnings Snapshot - Barchart.com
Organogenesis Holdings Inc. reports results for the quarter ended June 30Earnings Summary - tradingview.com
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript - The Globe and Mail
Form 8K Organogenesis Holdings Inc For: 6 August By Investing.com - Investing.com India
ORGO: Q2 2026 revenue plunged 58% and net loss widened sharply amid ongoing market and regulatory challenges - TradingView
Organogenesis (Nasdaq: ORGO) sets up $75M at-the-market stock sale - Stock Titan
Organogenesis Holdings Inc. Q2 2026: Revenue $42.8M, EPS $(0.77) — 10-Q Summary - tradingview.com
Organogenesis (NASDAQ: ORGO) hit by 58% sales drop and $149M first-half loss - Stock Titan
Organogenesis Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
Organogenesis Holdings reports Q2 2026 revenue $42.8M, net loss $96.3M - TradingView
Organogenesis Holdings Inc. Revises Revenue Guidance for the Second Half of the Year Ending December 31, 2026 - marketscreener.com
Organogenesis Holdings Inc (ORGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Organogenesis Holdings Inc 주식 (ORGO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Driscoll Michael Joseph | Director |
Mar 09 '26 |
Buy |
2.67 |
10,000 |
26,688 |
225,707 |
| Glenn Nussdorf | Director |
Dec 16 '25 |
Proposed Sale |
5.11 |
200,000 |
1,021,241 |
0 |
| NUSSDORF GLENN H | Director |
Dec 16 '25 |
Sale |
5.14 |
200,000 |
1,027,060 |
2,565,591 |
| NUSSDORF GLENN H | Director |
Nov 26 '25 |
Sale |
5.29 |
187,957 |
994,293 |
2,765,591 |
| NUSSDORF GLENN H | Director |
Nov 25 '25 |
Sale |
5.30 |
12,043 |
63,828 |
2,953,548 |
| Glenn Nussdorf | Director |
Nov 25 '25 |
Proposed Sale |
5.40 |
200,000 |
1,080,000 |
0 |
| Glenn Nussdorf | Director |
Nov 24 '25 |
Proposed Sale |
5.34 |
100,000 |
534,379 |
0 |
| NUSSDORF GLENN H | Director |
Nov 24 '25 |
Sale |
5.34 |
100,000 |
534,000 |
2,965,591 |
2.94%
0.88%
자본화:
|
볼륨(24시간):